Lv5
1400 积分 2022-09-12 加入
A colorimetric biosensor to track Trop-2 status of tumor cells for diagnosis of breast cancer
1个月前
已完结
DNA framework-controlled Poly(MOFs) as a visual platform for diagnosis of HER2-positive breast cancer
1个月前
已完结
Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer
1个月前
已完结
Single-cell multi-omic landscape reveals anatomical-specific immune features in adult and pediatric sepsis
6个月前
已完结
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
6个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
7个月前
已完结
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
8个月前
已完结
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
8个月前
已完结
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
8个月前
已完结
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
8个月前
已完结
皖公网安备34019202002308
